| Dr Delos J Clow, DO | |
|
2791 N Washington St, Hedrick Ob/gyn Associates, Chillicothe, MO 64601-2902 | |
| (660) 646-2682 | |
| (660) 214-8647 |
| Full Name | Dr Delos J Clow |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 2791 N Washington St, Chillicothe, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417949785 | NPI | - | NPPES |
| 207175902 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2004035412 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Delos J Clow, DO 2791 N Washington St, Hedrick Ob/gyn Associates, Chillicothe, MO 64601-2902 Ph: (660) 646-2682 | Dr Delos J Clow, DO 2791 N Washington St, Hedrick Ob/gyn Associates, Chillicothe, MO 64601-2902 Ph: (660) 646-2682 |
News Archive
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.
The University of Athens Medical School has conducted a comprehensive study to evaluate the relationship between diet quality, levels of physical activity and key lifestyle characteristics amongst a group of 12-17 year old schoolchildren. The objective was to determine the most appropriate health actions to reduce the risks of long-term cardiovascular disease. The study concludes that almost half of Greek schoolchildren have a low quality diet, while just 6 percent adhere to the traditional Mediterranean diet along with high levels of physical activity.
Scil Proteins today announced that it has concluded a financing round with its existing investor, BioNet Holding, worth €24 million. The funds are intended to finance the development of two products derived from the Company's Affilin platform into clinical Phase I over the next three years.
Researchers investigating the biochemical characteristics behind several everyday diseases have discovered a new chromosomal region to be strongly associated with the bad cholesterol, low density lipoprotein, (LDL).
› Verified 5 days ago
Yulia Peniston, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 861 Fairway Dr, Chillicothe, MO 64601 Phone: 913-680-9830 |